Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients.
暂无分享,去创建一个
L. Elting | G. Bodey | V. Fainstein | K. Rolston | P. Jones
[1] L. Elting,et al. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. , 1985, Archives of internal medicine.
[2] M. Keating,et al. Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients , 1984, Antimicrobial Agents and Chemotherapy.
[3] L. Elting,et al. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients. , 1984, Archives of internal medicine.
[4] E. Estey,et al. Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two. , 1984, Archives of internal medicine.
[5] J. Quinn,et al. Outbreak of JK diphtheroid infections associated with environmental contamination , 1984, Journal of clinical microbiology.
[6] J. Jorgensen,et al. In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli , 1984, Antimicrobial Agents and Chemotherapy.
[7] M. Marks,et al. In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients , 1984, Antimicrobial Agents and Chemotherapy.
[8] L. Elting,et al. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. , 1983, The Journal of antimicrobial chemotherapy.
[9] P. Wiernik,et al. Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. , 1982, Annals of internal medicine.
[10] L. Young,et al. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients. , 1982, Archives of internal medicine.
[11] R. Finley,et al. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin. , 1982, The American journal of medicine.
[12] G. Bodey,et al. Infectious complications in leukemic patients. , 1982, Seminars in hematology.
[13] C. Linnemann,et al. Bacteremia due to methicillin-resistant Staphylococcus aureus. , 1982, The Journal of infectious diseases.
[14] K. Bush,et al. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria , 1982, Antimicrobial Agents and Chemotherapy.
[15] R. H. Parker,et al. Bacteremia due to Staphylococcus aureus in patients with cancer: report on 45 cases in adults and review of the literature. , 1982, Reviews of infectious diseases.
[16] G. Bodey,et al. In vitro evaluation of Ro 13-9904 , 1980, Antimicrobial Agents and Chemotherapy.
[17] G. Harding,et al. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. , 1979, The American journal of medicine.
[18] W. Hewitt,et al. Antimicrobial synergism in the therapy of gram-negative rod bacteremia. , 1978, Chemotherapy.
[19] R. Feld,et al. Amikacin therapy of infections in neutropenic patients , 1975, The American journal of the medical sciences.
[20] J. Klastersky,et al. Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative Infections , 1972, Antimicrobial Agents and Chemotherapy.
[21] G. Bodey,et al. Infections in cancer patients. Results with gentamicin sulfate therapy , 1972, Cancer.